Profile: Biotech Consortium India Limited has been actively involved in technology transfer, project consultancy, fund syndication, information dissemination, manpower training & placement related to biotechnology. We are actively involved in capacity building activities in biosafety related to genetically modified organisms (GMOs). We provide technology for using a rDNA construct consisting of 3 immunodominant antigens & the expressed chimeric protein as a candidate for Brucella vaccine. The present technology involves the use of a multigenic construct encompassing 3 different immunodominant antigens (Cu-Zn superoxide dismutase (SOD), P39 antigen and L7/L12 ribosomal protein) of Brucella abortus as a vaccine candidate against brucellosis.